Listing Websites about Ironwood Pharmaceuticals
Home - Ironwood Pharmaceuticals
(1 days ago) Ironwood is a healthcare company dedicated to making a difference for people living with gastrointestinal (GI) diseases Ironwood Pharmaceuticals. Media Releases. September 2, 2021. Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences. August 26, 2021.
Ironwood Pharmaceuticals Inc. Cl A - MarketWatch
(8 days ago) Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need
Ironwood Pharmaceuticals, Inc. (IRWD) - Yahoo
(2 days ago) Ironwood Pharmaceuticals shares on Thursday rose after it said that the FDA approved a revised label for its Linzess treatment for irritable-bowel syndrome. The revised label warns of the risk of
Ironwood Pharmaceuticals - Wikipedia
(4 days ago) Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to
Here’s How Your Trade Ironwood Pharmaceuticals Inc. (IRWD
(2 days ago) Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) went down by -2.17% from its latest closing price compared to the recent 1-year high of $14.27. The company’s stock price has collected 0.22% of gains in the last five trading sessions. Press Release reported on 09/02/21 that Ironwood Pharmaceuticals to
Grants Management System - Ironwood Pharma
(4 days ago) Ironwood believes that it is important to give back to the communities in which we work and have a corporate presence. We routinely support non-profit service, medical education, and patient advocacy organizations whose primary focus is: (a) Consistent with Ironwood's therapeutic areas of interest, areas of expertise and concentration; and,
Press Releases - Ironwood Pharmaceuticals
(3 days ago) Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call. June 16, 2021. Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C) June 7, 2021.
Ironwood Pharmaceuticals Employee Reviews - Indeed
(9 days ago) Ironwood pharmaceuticals, started out as a really great company to work for. It was a small start up company with a single product. Senior leadership was great as well as management. But once the company made the executive decision of licensing a Gout medicine from AZ. The entire culture change which lead to a division of the company.
$IRWD: Investors will love the forecast for Ironwood
(3 days ago) Ironwood Pharmaceuticals, Inc. has a market cap of $2223516687. Stock Chart. Stock analysis is a method for investors and traders to make buying and selling decisions. Investors and traders try to gain an edge in the markets by making informed decisions through analyzing the past and current data. The ultimate goal is to arrive at a number that
Ironwood Pharmaceuticals Salaries - Glassdoor
(8 days ago) Ironwood Pharmaceuticals employees rate the overall compensation and benefits package 4.3/5 stars. What is the highest salary at Ironwood Pharmaceuticals? The highest-paying job at Ironwood Pharmaceuticals is a Director with a salary of $221,430 per year.
Ironwood Pharmaceuticals Inc Class A IRWD - Morningstar, Inc.
(Just Now) Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in
Is Ironwood Pharmaceuticals Inc. (IRWD) a Keeper? – News
(Just Now) Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) went up by 1.30% from its latest closing price compared to the recent 1-year high of $14.27. The company’s stock price has collected 1.30% of gains in the last five trading sessions. Press Release reported on 08/26/21 that Ironwood Pharmaceuticals Announ
Ironwood Pharmaceuticals, Inc. - Zacks Investment Research
(2 days ago) View Ironwood Pharmaceuticals, Inc. IRWD investment & stock information. Get the latest Ironwood Pharmaceuticals, Inc. IRWD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Working at Ironwood Pharmaceuticals: Employee Reviews
(2 days ago) Ironwood pharmaceuticals, started out as a really great company to work for. It was a small start up company with a single product. Senior leadership was great as well as management. But once the company made the executive decision of licensing a Gout medicine from AZ. The entire culture change which lead to a division of the company.
IRWD News Today (Ironwood Pharmaceuticals) - MarketBeat
(1 days ago) Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer finance.yahoo.com - August 3 at 12:05 PM: Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call finance.yahoo.com - July 22 at 8:01 PM: We Think Ironwood Pharmaceuticals (NASDAQ:IRWD) Can Manage Its Debt With Ease finance.yahoo.com - July 21 at 1:10 PM
Ironwood Pharmaceuticals - PitchBook
(7 days ago) Ironwood Pharmaceuticals General Information Description. Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic
Ironwood Pharmaceuticals Jobs and Company Culture - The Muse
(6 days ago) Ironwood Pharmaceuticals: We Are GI. Ironwood Pharmaceuticals is on a mission to advance the treatment of gastrointestinal (GI) diseases and redefine the standard of care for GI patients, and we believe we have the expertise and capabilities to get there.
Ironwood Pharmaceuticals, inc (IRWD) Q2 2021 Earnings Call
(9 days ago) Ironwood, along with AbbVie, entered into a settlement agreement with Teva Pharmaceuticals, providing a license to Teva for it's generic version of the 72 mcg LINZESS in the U.S. beginning March
Ironwood Pharmaceuticals - ZoomInfo
(5 days ago) Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for LINZESS® (linaclotide) based on clinical safety data that has been generated thus far …
Working at Ironwood Pharmaceuticals - Glassdoor
(2 days ago) Glassdoor gives you an inside look at what it's like to work at Ironwood Pharmaceuticals, including salaries, reviews, office photos, and more. This is the Ironwood Pharmaceuticals company profile. All content is posted anonymously by employees working at Ironwood Pharmaceuticals.
Ironwood Patient Assistance Program - NeedyMeds
(5 days ago) Ironwood Patient Assistance Program This program provides brand name medications at no or low cost: Provided by: Ironwood Pharmaceuticals, Inc. Languages Spoken: English, Others By Translation Service : Patient Assistance Applications : Generic Name Medications
Ironwood Pharmaceuticals, Inc. (IRWD) CEO - SeekingAlpha
(6 days ago) Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants. Meredith Kaya - VP, IR & Corporate Communications. Thomas McCourt
Q&A With Chris Hamilton of Ironwood Pharmaceuticals The Muse
(6 days ago) Ironwood Pharmaceuticals is more than just a company—it’s a group of people, each with unique perspectives and talents, who come together to create medicines that improve the lives of gastrointestinal (GI) patients. Joining Ironwood means becoming part of a diverse, inclusive, and collaborative team of individuals who like to challenge each
IRWD.O - Ironwood Pharmaceuticals, Inc. Profile Reuters
(Just Now) Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company. The Company is focused on the development and commercialization of GI product opportunities in areas of unmet need
Almas Qudrat - Senior Director Quality Unit - Talima
(8 days ago) Senior Director Quality operations at Ironwood Pharmaceuticals New York City Metropolitan Area. Gary Dodakian Senior Director at Genzyme Shrewsbury, MA. Michael Hyatt Retired - Senior Director of
Ironwood Pharmaceuticals Inc. (IRWD):Buy today, is the
(Just Now) Ironwood Pharmaceuticals Inc. (IRWD) saw an uptrend of 3.54% in the recent trading with $13.45 being its most recent. The current price level -5.75% lower than the highest price of $14.27 marked by the stock while trading over the past 52-weeks, whereas it is 55.85% higher than the lowest price of $8.63 the company dropped to over past 52-weeks.
Ironwood Pharmaceuticals, Inc. (IRWD) - Stock Analysis
(8 days ago) Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance. BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported financial results for second quarter 2021 and raised full year 2021 financial guid
Working At Ironwood Pharmaceuticals - Zippia
(1 days ago) The average employee at Ironwood Pharmaceuticals makes $92,841 per year, which is competitive for its industry and location. Some of its highest paying competitors, Karyopharm Therapeutics, Allergan, and Amylin Pharmaceuticals, pay $97,763, $94,157, and $92,758, respectively. Ironwood Pharmaceuticals is a medium pharmaceutical company with 674
Average Ironwood Pharmaceuticals Salary - Zippia
(8 days ago) As an employee at Ironwood Pharmaceuticals in the USA, you can expect to earn an average salary of $92,841 per year, or $44.64 an hour. However, there's a significant range between the top 10 percent of earners and the bottom 10 percent of earners. While the highest-paid employees at Ironwood Pharmaceuticals can earn over $140,000 a year, the
Ironwood Pharmaceuticals Announces Leadership Updates
(6 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome
For Ironwood Pharmaceuticals Inc. [IRWD - DBT News
(4 days ago) Ironwood Pharmaceuticals Inc. [NASDAQ: IRWD] surged by $0.51 during the normal trading session on Tuesday and reaching a high of $12.62 during the day while it closed the day at $12.58. The company report on June 16, 2021 that Ironwood Pharmaceuticals Announces That The American Journal of Gastroent
Ironwood Pharmaceuticals Stock Competitors - MarketBeat
(5 days ago) Ironwood Pharmaceuticals (NASDAQ:IRWD) and Vertex Pharmaceuticals (NASDAQ:VRTX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership.
Ironwood to cut 100 jobs after acid reflux - Yahoo! News
(7 days ago) Ironwood to cut 100 jobs after acid reflux drug fails study. (Reuters) - Ironwood Pharmaceuticals Inc <IRWD.O> said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn severity in a late-stage trial. Shares of the drugmaker fell 8% to $8
Ironwood Pharmaceuticals Company Profile - Craft
(1 days ago) Ironwood Pharmaceuticals (formerly Microbia) is dedicated to creating, developing, and commercializing innovative human medicines, and has clinical-stage programs in GI disorders and dyslipidemia. The Company discovers, develops and commercializes a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation